Skip to main content
Clinical Trials/CTRI/2026/01/100111
CTRI/2026/01/100111Not yet recruitingNot Applicable

Comparison of Efficacy of different doses of Magnesium Sulphate as an Adjuvant with Ropivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Block

Dr Bhanuprakash A1 site in 1 country60 target enrollmentStarted: January 11, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To compare the effect of MgSO4 in two doses (250 mg and 500 mg) on the

Study Overview

Brief Summary

This study is a randomised, double blind, parallel group, comparing the analgesic efficacy of 250mg vs 50g of magnesium sulphate with ropivacaine 0.75% in 60 patients undergoing orthopeadic upperlimb surgeries under supraclavicular brachial plexus block for 1.5 years.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient willing to provide informed written consent 2) ASA physical status grade 1 and 2 3) Patients undergoing Elective Orthopaedic upper limb surgeries under Supraclavicular Brachial Plexus Block.

Exclusion Criteria

  • Coagulation or bleeding disorders, Uncontrolled systemic diseases.
  • Local site infection 3)Any nerve injury/ neuropraxia/ paralysis 4)History of hypersensitivity to Ropivacaine 5)Cognitive or psychiatric disturbances.
  • Pregnant women.

Outcomes

Primary Outcomes

To compare the effect of MgSO4 in two doses (250 mg and 500 mg) on the

Time Frame: at 0hrs, 2hrs, 4hrs, 6hrs

duration of analgesia as an adjuvant to Ropivacaine in USG-guided

Time Frame: at 0hrs, 2hrs, 4hrs, 6hrs

supraclavicular BPB.

Time Frame: at 0hrs, 2hrs, 4hrs, 6hrs

Secondary Outcomes

  • To compare onset of sensory and motor blockade.(To assess the duration of sensory and motor blockade.)

Investigators

Sponsor
Dr Bhanuprakash A
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Bhanuprakash A

Bangalore Medical College and Research Institute

Study Sites (1)

Loading locations...

Similar Trials